HEIDELBERG PHARMA AG O.N./ DE000A11QVV0 /
| 15/11/2024 17:36:11 | Chg. -0.060 | Volume | Bid15/11/2024 | Ask15/11/2024 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 2.280EUR | -2.56% | 1,002 Turnover: 2,287.490 |
-Bid Size: - | -Ask Size: - | 77.92 mill.EUR | 0.00% | - |
Assets
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | .5000 | .4000 | .9000 | 2.1000 | 2.1000 | ||||||
| Intangible Assets | 1.4000 | 1.3000 | 1.2000 | 4.4000 | 4.1000 | ||||||
| Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Fixed Assets | 1.9000 | 1.9000 | 2.2000 | 12.8000 | 12.5000 | ||||||
| Inventories | 0.0000 | 0.0000 | .2000 | .5000 | .3000 | ||||||
| Accounts Receivable | 0.0000 | 5 | 0.0000 | .2000 | .3000 | ||||||
| Cash and Cash Equivalents | 12.1000 | 3.4000 | 1.9000 | 3.4000 | 23.4000 | ||||||
| Current Assets | 13.4000 | 10.1000 | 3.4000 | 8 | 25.2000 | ||||||
| Total Assets | 15.3000 | 12 | 5.6000 | 20.8000 | 37.7000 | ||||||
Liabilities
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1.8000 | 2.1000 | 2 | 1.4000 | .9000 | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | 0.0000 | 0.0000 | 0.0000 | 10.5000 | 2.6000 | ||||||
| Provisions | - | - | - | - | - | ||||||
| Liabilities | 9.5000 | 9 | 6.9000 | 25.3000 | 17.8000 | ||||||
| Share Capital | 3 | 3.4500 | 4.6000 | 5.4000 | 7.8250 | ||||||
| Total Equity | 5.8000 | 3 | -1.3000 | -4.5000 | 19.9000 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 15.3000 | 12 | 5.6000 | 20.8000 | 37.7000 | ||||||
Income Statement
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 3.2000 | 13 | 1.3000 | 11.7000 | 17.8000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -21.4000 | -12.9000 | -23.1000 | -13.4000 | -8.9000 | ||||||
| Interest Income | 1 | .2000 | - | -.5000 | -.5000 | ||||||
| Income Before Taxes | -20.4000 | -12.7000 | -23.1000 | -13.9000 | -9.4000 | ||||||
| Income Taxes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -20.4000 | -12.7000 | -23.1000 | -13.9000 | -9.4000 | ||||||
Per Share
Cash Flow
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -21.5000 | -18.4000 | -19.2000 | -9 | -5.1000 | ||||||
| Cash Flow from Investing Activities | 14.9000 | -.1000 | -.5000 | .6000 | -.2000 | ||||||
| Cash Flow from Financing | -.1000 | 9.8000 | 18.2000 | 9.8000 | 25.3000 | ||||||
| Decrease / Increase in Cash | -6.7000 | -8.7000 | -1.5000 | 1.5000 | 19.9000 | ||||||
| Employees | 66 | 71 | 80 | 124 | 128 | ||||||
